neohip: neoadjuvant her2-targeted therapy /- io with pembrolizumab
Published 1 year ago • 68 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
2:49
her2-e pcr with anti-her2-based neoadjuvant therapies
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
4:20
keynote 522: pembrolizumab as neoadjuvant treatment for early tnbc
-
1:29
the predictive value of treatment response after neoadjuvant therapy
-
0:55
neoadjuvant treatment approach for her2 positive breast cancer
-
3:01
alternate: neoadjuvant chemotherapy in er her2- breast cancer
-
7:15
characterizing the immune microenvironment before and following anti-her2 neoadjuvant therapy
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
2:50
results for pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer
-
6:45
her2 /er- breast cancer: neoadjuvant therapy options
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
3:28
neoadjuvant treatment strategies for her2-positive breast cancer
-
0:47
dr. yee on neoadjuvant pertuzumab in her2-positive breast cancer
-
3:47
dual her2-targeted neoadjuvant therapy for bc
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
1:25
dr. ellis on neoadjuvant endocrine therapy for breast cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
2:19
her2 heterogeneity and neoadjuvant therapy in breast cancer